BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 30059958)

  • 1. PTPN11 Gain-of-Function Mutations Affect the Developing Human Brain, Memory, and Attention.
    Johnson EM; Ishak AD; Naylor PE; Stevenson DA; Reiss AL; Green T
    Cereb Cortex; 2019 Jul; 29(7):2915-2923. PubMed ID: 30059958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PTPN11 Mutations in the Ras-MAPK Signaling Pathway Affect Human White Matter Microstructure.
    Fattah M; Raman MM; Reiss AL; Green T
    Cereb Cortex; 2021 Feb; 31(3):1489-1499. PubMed ID: 33119062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel effects of Ras-MAPK pathogenic variants on the developing human brain and their link to gene expression and inhibition abilities.
    Rai B; Naylor PE; Siqueiros-Sanchez M; Wintermark M; Raman MM; Jo B; Reiss AL; Green T
    Transl Psychiatry; 2023 Jul; 13(1):245. PubMed ID: 37407569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noonan syndrome, PTPN11 mutations, and brain tumors. A clinical report and review of the literature.
    Siegfried A; Cances C; Denuelle M; Loukh N; Tauber M; Cavé H; Delisle MB
    Am J Med Genet A; 2017 Apr; 173(4):1061-1065. PubMed ID: 28328117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel effects of Ras-MAPK pathogenic variants on the developing human brain and their link to gene expression and inhibition abilities.
    Rai B; Naylor P; Sanchez MS; Wintermark M; Raman M; Jo B; Reiss A; Green T
    Res Sq; 2023 Feb; ():. PubMed ID: 36865206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PTPN11 and KRAS gene analysis in patients with Noonan and Noonan-like syndromes.
    Brasil AS; Pereira AC; Wanderley LT; Kim CA; Malaquias AC; Jorge AA; Krieger JE; Bertola DR
    Genet Test Mol Biomarkers; 2010 Jun; 14(3):425-32. PubMed ID: 20578946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Learning and memory in children with Noonan syndrome.
    Pierpont EI; Tworog-Dube E; Roberts AE
    Am J Med Genet A; 2013 Sep; 161A(9):2250-7. PubMed ID: 23918208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant neuronal activity-induced signaling and gene expression in a mouse model of RASopathy.
    Altmüller F; Pothula S; Annamneedi A; Nakhaei-Rad S; Montenegro-Venegas C; Pina-Fernández E; Marini C; Santos M; Schanze D; Montag D; Ahmadian MR; Stork O; Zenker M; Fejtova A
    PLoS Genet; 2017 Mar; 13(3):e1006684. PubMed ID: 28346493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response to growth hormone in short children with Noonan syndrome: correlation to genotype.
    Binder G
    Horm Res; 2009 Dec; 72 Suppl 2():52-6. PubMed ID: 20029239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Arnold-Chiari malformation in Noonan syndrome and other syndromes of the RAS/MAPK pathway].
    Ejarque I; Millán-Salvador JM; Oltra S; Pesudo-Martínez JV; Beneyto M; Pérez-Aytés A
    Rev Neurol; 2015 May; 60(9):408-12. PubMed ID: 25912702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Occurrence of DNET and other brain tumors in Noonan syndrome warrants caution with growth hormone therapy.
    McWilliams GD; SantaCruz K; Hart B; Clericuzio C
    Am J Med Genet A; 2016 Jan; 170A(1):195-201. PubMed ID: 26377682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular and clinical studies in 107 Noonan syndrome affected individuals with PTPN11 mutations.
    Athota JP; Bhat M; Nampoothiri S; Gowrishankar K; Narayanachar SG; Puttamallesh V; Farooque MO; Shetty S
    BMC Med Genet; 2020 Mar; 21(1):50. PubMed ID: 32164556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PTPN11 (protein tyrosine phosphatase, nonreceptor type 11) mutations and response to growth hormone therapy in children with Noonan syndrome.
    Ferreira LV; Souza SA; Arnhold IJ; Mendonca BB; Jorge AA
    J Clin Endocrinol Metab; 2005 Sep; 90(9):5156-60. PubMed ID: 15956085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the PTPN11 gene in idiopathic short stature children and Noonan syndrome patients.
    Ferreira LV; Souza SC; Montenegro LR; Malaquias AC; Arnhold IJ; Mendonca BB; Jorge AA
    Clin Endocrinol (Oxf); 2008 Sep; 69(3):426-31. PubMed ID: 18331608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic landscape of RASopathies in Chinese: Three decades' experience in Hong Kong.
    Yu KPT; Luk HM; Leung GKC; Mak CCY; Cheng SSW; Hau EWL; Chan DKH; Lam STS; Tong TMF; Chung BHY; Lo IFM
    Am J Med Genet C Semin Med Genet; 2019 Jun; 181(2):208-217. PubMed ID: 30896080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural, Functional, and Clinical Characterization of a Novel PTPN11 Mutation Cluster Underlying Noonan Syndrome.
    Pannone L; Bocchinfuso G; Flex E; Rossi C; Baldassarre G; Lissewski C; Pantaleoni F; Consoli F; Lepri F; Magliozzi M; Anselmi M; Delle Vigne S; Sorge G; Karaer K; Cuturilo G; Sartorio A; Tinschert S; Accadia M; Digilio MC; Zampino G; De Luca A; Cavé H; Zenker M; Gelb BD; Dallapiccola B; Stella L; Ferrero GB; Martinelli S; Tartaglia M
    Hum Mutat; 2017 Apr; 38(4):451-459. PubMed ID: 28074573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SHP2 sails from physiology to pathology.
    Tajan M; de Rocca Serra A; Valet P; Edouard T; Yart A
    Eur J Med Genet; 2015 Oct; 58(10):509-25. PubMed ID: 26341048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and molecular characterization of children with Noonan syndrome and other RASopathies in Argentina.
    Chinton J; Huckstadt V; Moresco A; Gravina LP; Obregon MG
    Arch Argent Pediatr; 2019 Oct; 117(5):330-337. PubMed ID: 31560489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and molecular characterization of 40 patients with Noonan syndrome.
    Ferrero GB; Baldassarre G; Delmonaco AG; Biamino E; Banaudi E; Carta C; Rossi C; Silengo MC
    Eur J Med Genet; 2008; 51(6):566-72. PubMed ID: 18678287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dermatological manifestations in Noonan syndrome: a prospective multicentric study of 129 patients positive for mutation.
    Bessis D; Miquel J; Bourrat E; Chiaverini C; Morice-Picard F; Abadie C; Manna F; Baumann C; Best M; Blanchet P; Bursztejn AC; Capri Y; Coubes C; Giuliano F; Guillaumont S; Hadj-Rabia S; Jacquemont ML; Jeandel C; Lacombe D; Mallet S; Mazereeuw-Hautier J; Molinari N; Pallure V; Pernet C; Philip N; Pinson L; Sarda P; Sigaudy S; Vial Y; Willems M; Geneviève D; Verloes A; Cavé H
    Br J Dermatol; 2019 Jun; 180(6):1438-1448. PubMed ID: 30417923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.